Silence Therapeutics (SLN) Goodwill (2018 - 2026)

Silence Therapeutics (SLN) has 9 years of Goodwill data on file, last reported at $10.4 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill fell 2.48% year-over-year to $10.4 million; the trailing twelve-month figure through Mar 2026 stood at $10.4 million (down 2.48% YoY), and the FY2025 full-year result was $10.6 million, up 13.09% from the prior year.
• Goodwill declined to $10.4 million in Q1 2026, from $10.6 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $10.6 million in Q1 2025 to a low of $9.4 million in Q3 2024.
• A 5-year average of $10.0 million and a median of $10.1 million in 2024 frame the typical range for Goodwill.
• Across the five-year window, Goodwill dropped 8.21% in 2022 and grew 13.09% in 2025, its largest moves.
• Tracing SLN's Goodwill over 5 years: stood at $9.4 million in 2022, then grew by 3.58% to $9.7 million in 2023, then declined by 3.48% to $9.4 million in 2024, then increased by 13.09% to $10.6 million in 2025, then slipped by 2.48% to $10.4 million in 2026.
• Business Quant data shows SLN's Goodwill at $10.4 million in Q1 2026, $10.6 million in Q4 2025, and $10.6 million in Q3 2025.